Feels like they are a well oiled machine... taking a very methodical approach after only just getting IND clearance, with this step one that is leveraging off centres of excellence (already highly trained staff and well established relationships/connections within the medical network in the US) to fast track development.
I guess this is what they meant when they said they would be able to quickly pivot from a phase 1 study into a phase 2 study... it'll be manage by a very capable partner in the Moffit Cancer Centre who will be well equipped to expand trial sites and have the bodies on the ground to execute almost immediately.
Ann: Partnership with OncoBay Clinical to advance CHM 1101, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $2.886K | 721.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2421939 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18599873 | 22 |
View Market Depth
| Last trade - 09.59am 26/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |